Enhancement of sparc (osteonectin) synthesis in arthritic cartilage - Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures

被引:65
作者
Nakamura, S
Kamihagi, K
Satakeda, H
Katayama, M
Pan, H
Okamoto, H
Noshiro, M
Takahashi, K
Yoshihara, Y
Shimmei, M
Okada, Y
Kato, Y
机构
[1] HIROSHIMA UNIV,SCH DENT,DEPT BIOCHEM,MINAMI KU,HIROSHIMA 734,JAPAN
[2] BIOTECHNOL RES LABS,OHTU,JAPAN
[3] HOECHST JAPAN LTD,DRUG DISCOVERY RES LABS,KAWAGOE,SAITAMA 35011,JAPAN
[4] YAMANOUCHI PHARMACEUT CO LTD,CLIN PHARMACOL RES LABS,ITABASHI KU,TOKYO,JAPAN
[5] NATL DEF MED COLL,TOKOROZAWA,SAITAMA 359,JAPAN
[6] KANAZAWA UNIV,CANC RES INST,KANAZAWA,ISHIKAWA 920,JAPAN
来源
ARTHRITIS AND RHEUMATISM | 1996年 / 39卷 / 04期
关键词
D O I
10.1002/art.1780390402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To investigate the roles of SPARC (secreted protein, acidic and rich in cysteine) (osteonectin) in arthritis, using cartilage and synovium specimens and synovial fluids (SF) from patients with rheumatoid arthritis (RA) or osteoarthritis (OA), and to examine the effects of cytokines, growth factors, and hormones on SPARC Synthesis by chondrocytes in culture. Methods. SPARC in cartilage and synovium was immunostained with monoclonal antibodies, SPARC synthesis by cultured chondrocytes was measured by Northern blot analysis, immunoblotting, and sandwich enzyme-linked immunosorbent assay. Results. SPARC was identified in numerous chondrocytes in the superficial and middle zones and in regenerating chondrocytes of RA and OA joints, whereas such staining was absent in these zones of normal cartilage, except for weak signals from a few chondrocytes in the deep zone. In addition, SPARC synthesis was enhanced in synovial cells of RA and OA joints. The average SPARC level in SF was 10-fold higher in the RA than in the OA population, In rabbit articular chondrocyte cultures, administration of transforming growth factor beta 1 (TGF beta 1) and bone morphogenetic protein 2 increased SPARC levels at 24-48 hours, whereas interleukin-1 beta (IL-1 beta), IL-1 alpha, tumor necrosis factor alpha, lipopolysaccharide, phorbol myristate acetate, basic fibroblast growth factor, and dexamethasone decreased SPARC levels at 24-72 hours, TGF beta increased SPARC messenger RNA (mRNA) levels at 24 hours, whereas IL-1 beta caused a marked decrease in SPARC mRNA levels at 24 hours, Furthermore, IL-1 decreased the glycosylation of SPARC. Conclusion. These findings suggest that various growth factors and cytokines, including TGF beta 1 and IL-1 beta, regulate the production of SPARC by chondrocytes at pre- and posttranslational levels, and that SPARC synthesis is markedly enhanced in arthritic joints.
引用
收藏
页码:539 / 551
页数:13
相关论文
共 48 条
[1]   DEVELOPMENT OF CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS - CLASSIFICATION OF OSTEOARTHRITIS OF THE KNEE [J].
ALTMAN, R ;
ASCH, E ;
BLOCH, D ;
BOLE, G ;
BORENSTEIN, D ;
BRANDT, K ;
CHRISTY, W ;
COOKE, TD ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
KAPLAN, D ;
KOOPMAN, W ;
LONGLEY, S ;
MANKIN, H ;
MCSHANE, DJ ;
MEDSGER, T ;
MEENAN, R ;
MIKKELSEN, W ;
MOSKOWITZ, R ;
MURPHY, W ;
ROTHSCHILD, B ;
SEGAL, M ;
SOKOLOFF, L ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :1039-1049
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]  
BANDARA G, 1992, BIOL REGULATION CHON
[4]   OSTEONECTIN CDNA SEQUENCE REVEALS POTENTIAL BINDING REGIONS FOR CALCIUM AND HYDROXYAPATITE AND SHOWS HOMOLOGIES WITH BOTH A BASEMENT-MEMBRANE PROTEIN (SPARC) AND A SERINE PROTEINASE-INHIBITOR (OVOMUCOID) [J].
BOLANDER, ME ;
YOUNG, MF ;
FISHER, LW ;
YAMADA, Y ;
TERMINE, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (09) :2919-2923
[5]   OSTEONECTIN SPARC IS A PRODUCT OF ARTICULAR CHONDROCYTES/CARTILAGE AND IS REGULATED BY CYTOKINES AND GROWTH-FACTORS [J].
CHANDRASEKHAR, S ;
HARVEY, AK ;
JOHNSON, MG ;
BECKER, GW .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1221 (01) :7-14
[6]  
Cox R.A., 1968, METHODS ENZYMOL, V12, P120, DOI [10.1016/0076-6879, DOI 10.1016/0076-6879]
[7]   PURIFICATION AND TISSUE DISTRIBUTION OF A SMALL PROTEIN (BM-40) EXTRACTED FROM A BASEMENT-MEMBRANE TUMOR [J].
DZIADEK, M ;
PAULSSON, M ;
AUMAILLEY, M ;
TIMPL, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 161 (02) :455-464
[8]   ACTIVE AND LATENT FORMS OF TRANSFORMING GROWTH FACTOR-BETA ACTIVITY IN SYNOVIAL EFFUSIONS [J].
FAVA, R ;
OLSEN, N ;
KESKIOJA, J ;
MOSES, H ;
PINCUS, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01) :291-296
[9]   DIFFERENTIAL-EFFECTS OF SPARC AND CATIONIC SPARC PEPTIDES ON DNA-SYNTHESIS BY ENDOTHELIAL-CELLS AND FIBROBLASTS [J].
FUNK, SE ;
SAGE, EH .
JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 154 (01) :53-63
[10]   INTERLEUKIN-1 SUPPRESSES EXPRESSION OF CARTILAGE-SPECIFIC TYPE-II AND TYPE-IX COLLAGENS AND INCREASES TYPE-I AND TYPE-III COLLAGENS IN HUMAN CHONDROCYTES [J].
GOLDRING, MB ;
BIRKHEAD, J ;
SANDELL, LJ ;
KIMURA, T ;
KRANE, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (06) :2026-2037